Reduced tumor growth of cells mixed with NSAID-involution ECM in PPBC mice compared with control-involution ECM in np mice. Identified tenascin-C as potential mediator of tumor progression during involution that is decreased by NSAID treatment. This evidence concerns the gene TNC and neoplasm.